Two of the UK’s largest pension providers are building a £1 billion war chest to back homegrown science and technology companies. The initiative, called the Scale-Up Fund, represents a deliberate effort to keep British innovation funded by British capital, rather than watching promising startups flee to Silicon Valley for their growth-stage checks.
Nest and Railpen are spearheading the effort with support from the British Business Bank, the government-backed institution that exists precisely to fill gaps like this one. The fund targets companies that have already proven their concepts but need serious capital to commercialize technology, scale operations, and hire.
The Mansion House effect
This isn’t happening in a vacuum. The Scale-Up Fund is a direct descendant of the Mansion House Accord, signed in May 2025 by 17 pension providers who collectively promised to redirect more of their portfolios toward UK firms.
That accord was, in effect, a handshake between the pension industry and the government. The providers committed to boosting allocations to unlisted equities, startups, and infrastructure. The numbers involved are staggering: a £50 billion commitment from major funds toward venture capital and infrastructure investments.
In October 2025, the government doubled down by specifically calling for pension money to flow into future “sci-tech unicorns.” Nest, the UK’s largest workplace pension scheme by membership, has separately stated its ambition to invest up to £1 billion in venture capital by 2030. The Scale-Up Fund appears to be a major vehicle for delivering on that promise.
The competitive landscape for capital
The UK has been losing ground in the global competition for technology investment. British pension funds have historically allocated far less to domestic venture capital compared to their counterparts in the US, Canada, and Australia.
This dynamic has created a well-documented pattern. A British researcher develops breakthrough technology at a university like Oxford or Cambridge. The early seed money comes from UK angel investors or small venture funds. Then, when the company needs £50 million or £100 million to actually scale, American venture capital swoops in, the company redomiciles to Delaware, and the economic value creation happens overseas.
The Scale-Up Fund is designed to break that cycle at precisely the growth stage where UK capital has been absent. By pooling resources from multiple pension providers and leveraging the British Business Bank’s expertise in evaluating domestic companies, the fund creates a single investment vehicle large enough to write meaningful growth-stage checks.
The risks are real, though. Pension funds exist to pay retirees, not to serve as national industrial policy vehicles. The tension between fiduciary duty and patriotic capital allocation is genuine. If the fund’s investments underperform traditional gilt and equity portfolios, the backlash could set back institutional adoption of alternative assets by years.
Investors should watch two things closely. First, the fund’s governance structure, specifically how investment decisions get made and what return thresholds trigger escalation. Second, whether additional pension providers beyond Nest and Railpen commit capital. The difference between a £1 billion fund backed by two providers and a £1 billion fund backed by ten is enormous in terms of what it signals about institutional appetite for this kind of risk.